Science is Beautiful Blog

John Kouten, CEO

Recent Posts

Rider University PRSSA Hosts Crisis Communications Panel Discussion

Posted by John Kouten, CEO

Apr 2, 2015 9:20:00 AM

I was privileged to serve on a panel of experts at Rider University on March 31, 2015, discussing the role of public relations in a crisis.  

As a corporate communications officer for major global pharmaceutical companies, especially in my role as a product public relations executive, crisis communications was an ever-present aspect of my job.

The Rider PRSSA chapter convened a distinguished panel of experts (present company excluded) to discuss crisis communications best practices. And, based on the excellent direction of our student moderators, a number of key themes emerged.

Following are core strategies for successful crisis communications:

Plan: All organizations are at risk for a myriad of potential issues. PR pros should ensure that their organizations are prepared. No one can plan for an exact crisis, however, a close audit of your industry or non-profit sector will reveal common or potential issues. Plans with specific actions steps and processes should be drafted and drilled.

Read More

Topics: crisis communications

Biosimilars in the U.S.– A Myriad of Stakeholders Will Continue to Frame This Important Issue in 2015

Posted by John Kouten, CEO

Jan 12, 2015 7:03:57 PM

Ever since the Biologics and Price Competition and Innovation Act (BPCIA) of 2009 found its way into the Affordable Care Act, various stakeholders have been preparing for the U.S. introduction of these so-called “biosimilars.”

Novartis/Sandoz announced in July 2014 that EP2006 was the first 351(k) application accepted for review by US Food and Drug Administration (FDA), an event that occurred almost four and a half years after passage of the BPCIA.  And on January 7, 2015 the FDA Oncologic Drugs Advisory Committee (ODAC) recommended approval of Novartis/Sandoz’ investigational biosimilar filgrastim in the US. The Committee also recommended approval of the biosimilar for use in all indications included in the referenced product’s (Amgen’s NEUPOGEN®) label.

Read More

Topics: FDA, healthcare reform, biosimilars

Public Relations Society of America – Alive and Well in the City of Brotherly Love

Posted by John Kouten, CEO

Dec 3, 2014 4:30:00 PM

The Philadelphia Chapter of PRSA recognized their best and brightest last night (12/2/14) at the annual Pepperpot Awards. The #Pepperpots represent the high water mark for PR in the greater Delaware Valley (AKA Southeast PA, Delaware, South Jersey).

Read More

Topics: events, Agency Culture

A Decade of Dedication to Supporting Breast Cancer: JFK Communications Displays Strong Values; Strong Traditions

Posted by John Kouten, CEO

Oct 14, 2014 2:43:00 PM

At JFK Communications, we have had the distinct honor and privilege of participating in the Central and South Jersey (CSNJ) Susan G. Komen (www.komencsnj.org) Race for the Cure (RFTC) for the past 10 years!

Read More

Topics: JFK Communications, Advocacy, Agency Culture, Breast cancer, Susan G. Komen for the Cure Central and South Jers

Best Next Steps -- Two New FDA Digital Media Guidance Documents

Posted by John Kouten, CEO

Jul 2, 2014 9:30:00 AM

The FDA has issued the following two guidance documents:

Read More

The Drug Quality & Security Act – Impact Will Take Time

Posted by John Kouten, CEO

Mar 28, 2014 3:30:00 PM

On November 27, 2013, President Obama signed into law the Drug Quality and Security Act.  This law is updates the federal drug tracing and tracking system and outlines Federal Drug Administration (FDA) authority over compounding pharmacies.

In 2012, a large outbreak of meningitis was linked to unsanitary conditions at a compounding pharmacy.  Historically, the FDA had limited authority over compounding pharmacies, leaving oversight of the pharmacy to the states.

Read More

Topics: drug development, FDA

Engagement versus disruption -- The key to inbound marketing

Posted by John Kouten, CEO

Mar 6, 2014 10:00:00 AM


Inbound marketing represents a central shift in the way businesses market themselves creating wonderful opportunities for small businesses. If you happen to have a small business, inbound marketing awards you the fortuity of leveling the playing field and attracting new customers.  

Read More

Topics: public relations, digital communications, inbound marketing, digital marketing, content marketing, marketing professionals,

The Press Release is Dead. Long Live the Press Release

Posted by John Kouten, CEO

Feb 10, 2014 9:30:00 AM

 

The press release has been an important public relations tool since time immemorial. But with the death of the monolithic News Source and the rise of citizen reporting and social media, the press release is actually seeing resurgence in the field of inbound marketing. While the traditional press release is not nearly as relevant as it once was, in the world of inbound marketing there is wide open relevance that will not likely end soon. The following is a look into how press releases are evolving for the modern world.

Read More

Topics: public relations, science communications, inbound marketing, content marketing

E Marketing Congress Tries to Drag Pharma into the Light of Social Media

Posted by John Kouten, CEO

Nov 22, 2013 3:43:00 PM

Read More

Topics: facebook, Social media in pharma marketing, inbound marketing, digital marketing

Three-Day EPA Conference to Debate Corn Pesticides

Posted by John Kouten, CEO

Sep 12, 2013 1:53:00 PM


In case you missed it – and I did – the Federal Insecticide, Fungicide, and Rodenticide Act Scientific Advisory Panel (FIFRA SAP) will convene a three-day meeting (October 30-November 1, 2013). The details are hidden here

FIFRA SAP is an extremely influential and powerful panel.  It   serves as the primary scientific peer review mechanism of EPA’s Office of Chemical Safety and Pollution Prevention (OCSPP) and is structured to provide scientific advice, information and recommendations to the EPA Administrator on pesticides and pesticide-related issues as to the impact of regulatory actions on health and the environment.

Read More

Topics: chemical companies, crop protection, crop science, pesticides, fungicides, insecticides

 

Most Popular

Recent Posts

Posts by tags

see all